Speaker List

We welcome our 2019 Speaking Faculty, including:

Dr. Najah Abi-Gerges, VP R&D, R&D, AnaBios Corp

Dr. Nathalie Marie Agar, Assoc Prof, Neurosurgery, Brigham & Women’s Hospital

Dr. Christopher Am Ende, Senior Principal Scientist, Neurosciences Medicinal Chemistry, Pfizer Global R&D Groton Labs

Dr. Alejandro Amador, Scientific Leader, GlaxoSmithKline

Dr. Blake Anson, PhD, Director, Marketing, StemoniX

 

Dr. Elnaz Atabakhsh, Senior Product Manager, Multiplex Assays, Abcam

Dr. Samira Azarin, Asst Prof, Chemical Engineering & Materials Science, Univ of Minnesota Twin Cities

Dr. Leonora Balaj, Instructor, Neurosurgery, Massachusetts General Hospital

Dr. Michael Benecky, Sr Dir Global Regulatory Affairs, Precision & Digital Medicine Pharma R&D, GlaxoSmithKline

Dr. Peter Bergethon, VP, Quantitative Medicine & Clinical Technologies, Biogen

Dr. Ruben Boado, CoFounder & VP R&D, R&D, ArmaGen Inc

Dr. Jayaprakasam Bolleddula, Drug Metabolism & Pharmacokinetics, Takeda Pharmaceuticals Inc

Dr. Ramakrishna Boyanapalli, Assoc Dir Bioanalytic & Pharmacology & Biomarker, Bioanalytic & Pharmacology & Biomarker Dev, WAVE Life Sciences USA Inc

Dr. Stefan Braam, CEO, Ncardia

Dr. Nicholas Brandon, Chief Scientist, Neuroscience, AstraZeneca Pharmaceuticals

Dr. Arne Bruyneel, PostDoc Research Fellow, Cardiovascular Research Institute, Stanford Univ

Christopher Bunker, PhD, MBA, Senior Vice President, Business Development, Advanced Cell Diagnostics (ACD), a Bio-Techne brand

Dr. Arijit Chakravarty, CEO, Fractal Therapeutics

Dr. Zhao Chen, Investigator III, Exploratory Immuno Oncology, Novartis Institutes for BioMedical Research Inc

Dr. Jonathan Cheng, Assoc VP Oncology Clinical Dev, Oncology Clinical Dev, Merck Research Labs

Adrian Chernoff, Former Worldwide VP & Global Head R&D, Email Address Only

An Chi, Principal Scientist, Merck Research Labs

Dr. Colin Choi, Scientist, Drug Safety Research & Evaluation, Takeda Pharmaceuticals Inc

Dr. Raphael Clynes, VP Translational Biology, Translational Biology, Xencor Inc

Dr. Robert Copeland, Co-Founder & President & CSO, Accent Therapeutics Inc

Andy Coravos, Co-founder & CEO, Elektra Labs

Dr. Adil Daud, Prof, Hematology & Oncology, Univ of California San Francisco

Dr. Karen DeBalsi, PhD, Senior Study Director, Metabolon, Inc.

 

Dr. Silvia De Paoli Lacerda, Senior Scientist, Chemist, FDA CBER

Flavia De Santis, R&D, Scientist, Scientific department, ZeClinics

 

Dr. Paul Diehl, COO, Cellecta

Dr. Christine Dingivan, Global Head, Global Drug Dev Data & Digital, Novartis Pharmaceuticals

Dr. Rakesh Dixit, President & CEO, Bionavigen

Dr. Dario Doller, Sr Dir Exploratory Research, Exploratory Research, SAGE Therapeutics

Dario Doller, Senior Research Fellow, Nuerogen Corp

Dr. David Donabedian, Co-Founder & CEO & Dir, Axial Biotherapeutics Inc

Dr. Katherine Donovan, Scientist, Cancer Biology, Dana Farber Cancer Institute

Dr. Sean Downing, PhD, MBA, Director of Customer Engagement, Ultivue

 

Dr. Nicholas Dracopoli, PhD, Strategic Advisor, Mission Bio

 

Dr. David Drewry, Research Assoc Prof, Chemical Biology Ctr, Univ of North Carolina Chapel Hill

Dr. Roxana Dronca, Asst Prof, Oncology, Mayo Clinic & Foundation

Dr. Michael Drummond, Scientific Applications Manager, Chemical Computing Group

Dr. David Duffy, PhD, Chief Technology Officer, Quanterix Corporation

 

Dr. Michael Dunn, Sr Staff Scientist, Cardiovascular Research, Regeneron Pharmaceuticals Inc

Chris Economos, Vice President, Business Development, physIQ

 

Fritz Eibel, Senior Vice President, MolecularMD

 

Dr. Jason Ekert, Head, Complex In Vitro Models, GlaxoSmithKline

Dr. Margot El-Khouri, PhD, Immunology Sales Specialist, ProImmune

 

Dr. Sandra Engle, Dir Translational Cellular Sciences, Stem Cells & Genomic Engineering, Biogen

Shawn Evans, Director, Edge Technologies, Valorem Reply

 

Justin Fairchild, Exec Dir Clinical Dev, Parker Institute for Cancer Immunotherapy

Dr. Stephen Fawell, VP & Head iScience, Oncology & IMED Biotech, AstraZeneca Pharmaceuticals

Dr. Stephen Fawell MERGE, VP & Head, Oncology iScience, AstraZeneca Pharmaceuticals

Dr. Yuehan Feng, Biognosys AG

Dr. Eric Fischer, Asst Prof & Principal Investigator, Biological Chemistry & Molecular Pharmacology, Dana Farber Cancer Institute

Maria Fitzgerald, Dir, sanofi Grp

Keith Flaherty, Director, Clinical Research, Massachusetts General Hospital Cancer Center

 

Dr. Fernande Freyermuth, PostDoc Researcher, Institute for Neurodegenerative Diseases, Massachusetts General Hospital

Emma Gargus, Graduate Student, Northwestern Univ

Dr. Lara Gechijian, Scientist & Project Lead, Chemical Biology, Jnana Therapeutics

Dr. Nicholas Geissse, PhD, CSO, NanoSurface Biomedical

 

Dr. Gary Gintant, Research Fellow Drug Discovery, Integrated Sciences & Technology, AbbVie Inc

Dr. Charles Glaus, Dir Translational Research & Early Clinical Dev, Translational Research & Early Clinical Dev, Takeda Pharmaceuticals Inc

Dr. Murali Gopalakrishnan, Sr Dir & Head, Search & Evaluation Neuroscience, AbbVie Inc

Balaji Goparaju, Data Scientist, Novartis Institutes for BioMedical Research Inc

Gera Goverse, PhD, OcellO

 

Dr. Norman Greenberg, CSO & Sr VP R&D, R&D, Atreca Inc

Thomas Goss, PharmD, Senior Vice President, Boston Healthcare Associates, Inc.

Gera Goverse, PhD, OcellO

Dr. Chenghua Gu, Asst Prof, Neurobiology, Harvard Medical School

Daniel Haag, CSO and Co-Founder, NeuCyte

Dr. Marzieh Haghighi, PostDoc Assoc, Imaging Platform, Broad Institute

Dr. Abdel Halim, VP, Biomarkers and Companion Diagnostics, Taiho Oncology, Inc.

Taleen Hanania, PhD, Senior Vice President, Behavioral Pharmacology, PsychoGenics Inc.

Dr. Christopher Hartshorn, Program Dir, Cancer Treatment & Diagnosis, NIH NCI

Michael Hiatt, Senior Scientist, Bioengineering Research and Development, STEMCELL Technologies

Nikola Hunter, Principal Scientist, Translational Biology, Concept Life Sciences

Pooja Jain, Senior Product Manager, Life Science Solutions, Elsevier

Darshana Jani, Associate Director, Global Lead, Biologics, Pfizer

Dr. Jamileh Jemison, Head of Clinical Development, HealthMode

Dr. Russell Jenkins, Asst Prof Medicine, Ctr for Cancer Research, Massachusetts General Hospital

Dr. Kamal Jethwani, Sr Dir, Connected Health Innovation, Partners HealthCare

Dr. Xiaomo Jiang, Investigator, Immuno Oncology, Novartis Institutes for BioMedical Research Inc

Barbara Joyce-Shaikh, Principal Scientist, Merck Research Labs

Dr. Vivek Kadambi, Sr VP Nonclinical Dev, Nonclinical Dev, Blueprint Medicines

Dr. Hansjoerg Keller, Sr Investigator I, Musculoskeletal Diseases, Novartis Institutes for BioMedical Research

Dr. Leonard Khiroug, PhD, CSO, Neurotar Ltd

 

Dr. Edward Kim, Chairman, Solid Tumor Oncology & Investigational Therapeutics, Levine Cancer Institute

Dr. Christian Klose, Head, R&D, Lipotype GmbH

Andreas Koepke, Managing Director, BD OmicScouts

 

Dr. Tania Konry, Asst Prof, Pharmaceutical Sciences, Northeastern Univ

Dr. Milka Kostic, Program Director, Chemical Biology, Dana Farber Cancer Institute

Dr. Nava Krishnan, Research Investigator, Biochemistry, Cold Spring Harbor Lab

Dr. Silvia Lacerda, Assoc, FDA CBER

Dr. Dana Larocca, VP R&D, R&D, ReCyte Therapeutics Inc

Dr. Volker Lauschke, Grp Leader Personalized Medicine & Drug Dev, Physiology & Pharmacology, Karolinska Institute

Dr. Vivian Lee, Postdoctoral Research Associate, Department of Bioengineering, Northeastern University

Dr. Bo Yeon Lee, Scientific Program Mgr, NIH NCATS

Dr. Emma Lees, VP & Site Head, Oncology, Bristol Myers Squibb Co

Pierre Leurent, CEO, Voluntis

Dr. Jonathan Levenson, VP Translational Biology, Translational Biology, Tiaki Therapeutics Inc

Jill Loftiss, Head, MedImmune

Dr. Irena Loryan, Researcher, Pharmaceutical Biosciences, Uppsala Univ

Dr. Eugen Lounkine, Sr Investigator I, Novartis Institutes for BioMedical Research Inc

Amanda Lowe, Managing Director, Visiopharm Corporation

 

John Lowe, MD, Principal, Lowe Consulting

Dr. Per Lundin, COO, Evox Therapeutics Ltd

Dr. Johan Luthman, VP Neuroscience Clinical Dev, Neuroscience Clinical Dev, Eisai Inc

Dr. Loui Madakamutil, PhD, SVP & Head of Preclinical Development, Nektar Therapeutics

Dr. Danilo Maddalo, Lab Head, ONC Pharmacology, Novartis Institutes for BioMedical Research

Suresh Madhavan, CEO, PointCross Life Sciences

 

Dr. Wasim Malik, Assistant Professor, Harvard Medical School; Managing Partner, Iaso Ventures

Dr. Graham Marsh, Scientist I, Translational Cell Sciences, Biogen

Dr. Chad May, VP R&D, R&D, Maverick Therapeutics Inc

Dr. Fahar Merchant, PhD, President & CEO, Medicenna Biopharma

 

Dr. Jennifer Michaelson, VP Preclinical Research & Early Dev, Preclinical Research & Early Dev, Cullinan Oncology LLC

Dr. Adel Mikhail, CSO, Discovery Life Sciences

Dr. Maria Mirotsou, Sr Dir Research, Research, Astellas Institute for Regenerative Medicine AIRM

Dr. Jeffrey Moffitt, PostDoc Fellow, Chemistry & Chemical Biology, Harvard Univ

Dr. Stephen Morairty, Dir, Center for Neuroscience, SRI Intl

Dr. Jennifer Morrissette, Clinical Dir & Assoc Prof, Ctr for Personalized Diagnostics, Univ of Pennsylvania

Dr. Merrie Mosedale, Research Asst Prof, Institute for Drug Safety Sciences, Univ of North Carolina Chapel Hill

Dr. Arantza Muriana, CEO, BIOBIDE USA

Brian Neman, CEO, Sanguine Biosciences

Dr. Deepak Nijhawan, Asst Prof, Internal Medicine & Biochemistry, Univ of Texas Dallas

Shahriar Niroomand, Sr Scientist, Merck & Co Inc

Dr. Ryan Nolan, Sr Scientist, Takeda Pharmaceuticals Inc

Dr. Carrie Northcott, Project Team Lead, Innovation Research Lab, Pfizer Inc

Raj Pallapothu, Global Lead, Bayer HealthCare Pharmaceuticals

Taciana Pereira, Dir Bioengineering, Allevi Inc

Dr. Valerio Pereno, PhD, Business Development, ONI

 

Dr. Elaine Pinheiro, Principal Scientist In Vivo Pharmacology, Immuno Oncology, Merck Research Labs

Matt Pipke, CTO, physIQ

 

Dr. Mark Poznansky, Dir & Assoc Prof Medicine, Vaccine & Immunotherapy Ctr, Massachusetts General Hospital

Dr. Rachelle Prantil-Baun, Sr Staff Scientist, Advanced Technology Team, Harvard Univ

Dr. William Proctor, Assoc Dir Investigative Toxicology, Investigative Toxicology, Genentech Inc

Katrin Schlie, Business Development Manager, ProQinase

 

Dr. Jianwen Que, Assoc Prof, Medicine, Columbia Univ

Dr. Elizabeth Quinn, Assoc Dir Stem Cell Marketing, Stem Cell Marketing, Takara Bio USA Inc

Ashoka Rajendra, Head, Product, Molecular Biology and Inventory, Benchling

Dr. Deepak Rajpal, Sr Scientific Dir Computational Biology, Computational Biology, GlaxoSmithKline

Dr. Arvind Rao, Assoc Prof, Computational Medicine & Bioinformatics, Univ of Michigan

Dr. Steven Richards, Investigator, Biomarker Dev, Novartis Institutes for BioMedical Research Inc

Kristin Rockwell, Research Scientist, Pfizer Global R&D Groton Labs

Hunter Rogers, Graduate Student, Northwestern Univ

Dr. Louis Scampavia, Assoc Prof & Dir HTS Chemistry & Technologies, HTS Chemistry & Technologies, Scripps Research Institute

Dr. Christian Schmees, Grp Leader, Tumor Biology, Univ of Tuebingen

Dr. Emmett Schmidt, Assoc VP, Merck Research Labs

Omri Shor, CEO & Co-Founder, Medisafe

 

Guru Singh, Head, Growth, LabTwin

Andrew Scott, Head, Bioassay Development and Screening, Screening and Assay Development, Concept Life Sciences

Ting Shih, CEO & Founder, ClickMedix

Dr. Anna-Karin Sjoegren, Discovery Safety Specialist, AstraZeneca R&D

Dr. Aleksander Skardal, Asst Prof, Wake Forest Univ

Dr. Dimitris Skokos, Assoc Dir Immune & Inflammatory Diseases, Immune & Inflammatory Diseases, Regeneron Pharmaceuticals Inc

Dr. Alec S.T. Smith, PhD, Acting Instructor, Bioengineering, University of Washington

 

Dr. Benjamin Smith, Scientist II, Engineering & Biologics Design, Biogen

Dr. Holly Soares, Head, Translational Neuroscience, AbbVie Inc

Perceval Sondag, Sr Mgr, PharmaLex GmbH

Dr. Carrie Sougnez Cibulskis, PhD,  Director, Somatic Portfolio,  The Broad Institute

 

Dr. Hao Sun, Principal Pharmacokineticist, Drug Metabolism & Pharmacokinetics, Seattle Genetics Inc

Dr. Yishan Sun, Investigator III, Neuroscience, Novartis Institutes for BioMedical Research Inc

Dr. Fangxian Sun, Lead Research Investigator, Pharmacology, sanofi Grp

Dr. Masataka Suzuki, Asst Prof, Gene Therapy Ctr, Baylor College of Medicine

Dr. Shuichi Takayama, Prof, Biomedical Engineering, Georgia Institute of Technology

Dr. Michael Tetzlaff, Assoc Prof, Pathology & Anatomical, MD Anderson Cancer Ctr

Dr. Herve Tiriac, Assoc Project Scientist, Surgery, Univ of California San Diego

Dr. Elizabeth Trehu, CMO, Jounce Therapeutics Inc

Nathan Treloar, President & Co-Founder, Orbita

Dr. Katya Tsaioun, Director, Evidence-Based Toxicology Collaboration, Johns Hopkins Bloomberg School of Public Health

Dr. Vanessa Tumilasci, Commercial Dir Bus Dev, Bus Dev, Trans Hit Biomarkers Inc

Dr. Laszlo Urban, Global Head Preclinical Secondary Pharmacology, Preclinical Safety, Novartis Institutes for BioMedical Research Inc

Dr. Manthena Varma, Assoc Research Fellow, Pfizer Inc

Dr. Fabien Vincent, Assoc Research Fellow & Lab Head, WRD, Pfizer Inc

Dr. Michael Vishnevetsky, Head, Global Business Development, Invivoscribe

Dr. Bridget Wagner, Dir Pancreatic Cell Biology & Metabolic Diseases, Ctr for the Science of Therapeutics, Broad Institute

Sean Walsh, PhD, CSO, Oncoradiomics

 

Dr. Changning Wang, Asst Prof, Radiology, Massachusetts General Hospital

Greg Warner, PhD, Senior Field Applications Scientist, Quanterix Corporation

Dr. Cong Wei, Sr Scientist & Grp Leader, Vertex Pharmaceuticals Inc

Dr. George Wei, Vice President, Research & Development, ACT Genomics

Nienke Wevers, Scientist, MIMETAS BV

Dr. Theresa Whiteside, Prof, Pathology & Immunology & Otolaryngology, Univ of Pittsburgh

Dr. Sybil Williams, Dir Biology Oncology Discovery, Biology Oncology Discovery, Merck Research Labs

Dr. Juliet Williams, Exec Dir Oncology Drug Discovery, Oncology Drug Discovery, Novartis Pharmaceuticals UK Ltd

Jeffrey Willy, Research Fellow, Vertex Pharmaceuticals R&D Inc

Dr. Janica CheukYing Wong, Sr Scientist Translational Pathology, Profiling & Expression, Merck Research Labs

Dr. Guangqing Xiao, Dir Drug Metabolism & Pharmacokinetics, Discovery Sciences, Sunovion Pharmaceuticals Inc

Dr. Xin Xu, Research Fellow, PreClinical Innovation, NIH NCATS

Dr. Jaydeep Yadav, Scientist, Amgen Inc

Dr. Zhengyin Yan, Sr Scientist, Drug Metabolism & Pharmacokinetics, Genentech Inc

Dr. Paul Young, Exec Dir, BD&L, Merck Research Labs

Dr. Yuan Zhang, PhD, Vice President, BD/Marketing & Logistics,  Pharmalegacy

 

Dr. Yu Shrike Zhang, Instructor, Medicine, Brigham & Women’s Hospital

Dr. Donglu Zhang, Principal Scientist, Genentech Inc

Dr. Xuemei Zhao, Sr Principal Scientist, Translational Molecular Biomarkers, Merck Research Labs